Financial Health Scores: Healthcare

Top Healthcare companies by financial health score. Each score is a 0-100 composite of six dimensions ranked as percentiles within the company's peer group (banks against banks, REITs against REITs), so it measures standing among peers rather than absolute cross-industry strength.

Rates the quality of the business, not whether the stock is cheap. A 0–100 composite of profitability, growth, leverage, liquidity, cash flow, and returns.

A high score means strong fundamentals, but not a guaranteed good trade. A great business can still be a bad buy at the wrong price.

Banks, REITs, insurers, and early-stage companies are scored on sector-tailored metrics. Full methodology →

Research tool, not financial advice. Use alongside valuation analysis and your own view of the business.

Data as of FY 2025 100 companies Rhea AI

# Company Dimensions

SLGL Sol-Gel Technologies L… Emerging Data Issue 91 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 2

KROS Keros Therapeutics, In… Emerging Check Earnings Data Issue 91 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 3

CPRX Catalyst Pharmaceutica… Check Earnings 89 Profit Growth Debt Cash Flow Return 4/9 Safe 4

UTHR United Therapeutics Co… 88 Profit Growth Debt Cash Flow Return 7/9 Safe 5

HRMY Harmony Biosciences Ho… 88 Profit Growth Debt Cash Flow Return 5/9 Safe 6

DOCS Doximity, Inc. 88 Profit Growth Debt Cash Flow Return 5/9 Safe 7

XLO Xilio Therapeutics, In… Emerging Check Earnings Data Issue 87 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 8

RMD ResMed Inc. 87 Profit Growth Debt Cash Flow Return 7/9 Safe 9

ISRG Intuitive Surgical, In… 86 Profit Growth Debt Cash Flow Return 7/9 Safe 10

IRMD IRADIMED CORPORATION 86 Profit Growth Debt Cash Flow Return 5/9 Safe 11

IDYA IDEAYA Biosciences, In… Emerging Check Earnings Data Issue 84 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 12

STOK Stoke Therapeutics, In… Emerging Check Earnings Data Issue 83 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 13

INVA Innoviva, Inc. Check Earnings Data Issue 83 Profit Growth Debt Cash Flow Return 5/9 Safe 14

LMAT LeMaitre Vascular, Inc… 81 Profit Growth Debt Cash Flow Return 6/9 Safe 15

ADMA ADMA Biologics, Inc. Check Earnings 81 Profit Growth Debt Cash Flow Return 5/9 Safe 16

NUTX Nutex Health Inc. One-time Loss 80 Profit Growth Debt Cash Flow Return 7/9 Safe 17

NBIX Neurocrine Biosciences… 80 Profit Growth Debt Cash Flow Return 4/9 Safe 18

HNGE Hinge Health, Inc. Emerging Data Issue 80 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 19

EXEL Exelixis, Inc. 80 Profit Growth Debt Cash Flow Return 6/9 Safe 20

ANAB AnaptysBio, Inc. Emerging Check Earnings Data Issue 80 Cash Dil R&D RevPS Burn BalSh 5/9 Grey 21

ELMD Electromed, Inc. Check Earnings 79 Profit Growth Debt Cash Flow Return 5/9 Safe 22

DCTH Delcath Systems, Inc. Emerging Data Issue 79 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 23

CGEN Compugen Ltd. Emerging Check Earnings Data Issue 79 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 24

UTMD Utah Medical Products,… 78 Profit Growth Debt Cash Flow Return 6/9 Safe 25

SMLR Semler Scientific, Inc… Check Earnings 78 Profit Growth Debt Cash Flow Return 3/9 Safe 26

REGN Regeneron Pharmaceutic… 78 Profit Growth Debt Cash Flow Return 4/9 Safe 27

HALO Halozyme Therapeutics,… 78 Profit Growth Debt Cash Flow Return 5/9 Safe 28

CORT Corcept Therapeutics I… 78 Profit Growth Debt Cash Flow Return 4/9 Safe 29

ARWR Arrowhead Pharmaceutic… Emerging Check Earnings Data Issue 78 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 30

GMED Globus Medical, Inc. 77 Profit Growth Debt Cash Flow Return 8/9 Safe 31

ZYME Zymeworks Inc. Emerging Data Issue 76 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 32

WST West Pharmaceutical Se… 76 Profit Growth Debt Cash Flow Return 7/9 Safe 33

TBPH Theravance Biopharma, … Emerging Data Issue 76 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 34

PTGX Protagonist Therapeuti… Emerging Data Issue 76 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 35

IDXX IDEXX Laboratories, In… 76 Profit Growth Debt Cash Flow Return 8/9 Safe 36

BMRN BioMarin Pharmaceutica… 76 Profit Growth Debt Cash Flow Return 4/9 Safe 37

PODD Insulet Corporation 75 Profit Growth Debt Cash Flow Return 6/9 Safe 38

MDXG MiMedx Group, Inc. Data Issue 75 Profit Growth Debt Cash Flow Return 5/9 Safe 39

XFOR X4 Pharmaceuticals, In… Emerging Check Earnings Data Issue 74 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 40

VRTX Vertex Pharmaceuticals… 74 Profit Growth Debt Cash Flow Return 6/9 Safe 41

TECH Bio-Techne Corporation 74 Profit Growth Debt Cash Flow Return 7/9 Safe 42

RXST RxSight, Inc. Emerging Data Issue 74 Cash Dil R&D RevPS Burn BalSh 1/9 Grey 43

INMD InMode Ltd. 74 Profit Growth Debt Cash Flow Return 3/9 Safe 44

BCRX BioCryst Pharmaceutica… Data Issue 74 Profit Growth Debt Cash Flow Return 7/9 Grey 45

ARVN Arvinas, Inc. Emerging Check Earnings Data Issue 74 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 46

KURA Kura Oncology, Inc. Emerging Check Earnings Data Issue 73 Cash Dil R&D RevPS Burn BalSh 2/9 Distress 47

EW Edwards Lifesciences C… 73 Profit Growth Debt Cash Flow Return 6/9 Safe 48

CRON Cronos Group Inc. Emerging Check Earnings Data Issue 73 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 49

ALKS Alkermes plc 73 Profit Growth Debt Cash Flow Return 5/9 Safe 50

UFPT UFP Technologies, Inc. 72 Profit Growth Debt Cash Flow Return 7/9 Safe 51

TXG 10x Genomics, Inc. Emerging 72 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 52

PDEX Pro-Dex, Inc. Check Earnings 72 Profit Growth Debt Cash Flow Return 7/9 Safe 53

FDMT 4D Molecular Therapeut… Emerging Check Earnings Data Issue 72 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 54

YMAB Y-mAbs Therapeutics, I… Emerging Data Issue 71 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 55

WAT Waters Corporation 71 Profit Growth Debt Cash Flow Return 4/9 Safe 56

TCMD Tactile Systems Techno… 71 Profit Growth Debt Cash Flow Return 7/9 Safe 57

NNNN Anbio Biotechnology Check Earnings Data Issue 71 Profit Growth Debt Cash Flow Return 4/9 Safe 58

MIRM Mirum Pharmaceuticals,… Emerging Data Issue 71 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 59

LNTH Lantheus Holdings, Inc… Check Earnings 71 Profit Growth Debt Cash Flow Return 5/9 Safe 60

ANIK Anika Therapeutics, In… Emerging 71 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 61

TVTX Travere Therapeutics, … Emerging Check Earnings Data Issue 70 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 62

PRLD Prelude Therapeutics I… Emerging Data Issue 70 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 63

PGNY Progyny, Inc. 70 Profit Growth Debt Cash Flow Return 5/9 Safe 64

NEUP Neuphoria Therapeutics… Emerging 70 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 65

MDGL Madrigal Pharmaceutica… Emerging Check Earnings Data Issue 70 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 66

LGND Ligand Pharmaceuticals… 70 Profit Growth Debt Cash Flow Return 4/9 Safe 67

JANX Janux Therapeutics, In… Emerging Data Issue 70 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 68

AMPH Amphastar Pharmaceutic… 70 Profit Growth Debt Cash Flow Return 6/9 Grey 69

AGIO Agios Pharmaceuticals,… Emerging Check Earnings Data Issue 70 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 70

VCYT Veracyte, Inc. 69 Profit Growth Debt Cash Flow Return 7/9 Safe 71

TNXP Tonix Pharmaceuticals … Emerging Data Issue 69 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 72

SRDX Surmodics, Inc. Emerging 69 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 73

SONN Sonnet BioTherapeutics… Emerging Check Earnings Data Issue 69 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 74

PEN Penumbra, Inc. 69 Profit Growth Debt Cash Flow Return 6/9 Safe 75

PBYI Puma Biotechnology, In… Check Earnings Data Issue 69 Profit Growth Debt Cash Flow Return 7/9 Distress 76

MMSI Merit Medical Systems,… 69 Profit Growth Debt Cash Flow Return 7/9 Safe 77

KYNB Kyntra Bio, Inc. Emerging Check Earnings Data Issue 69 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 78

FGEN FibroGen, Inc. Emerging Check Earnings Data Issue 69 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 79

DXCM DexCom, Inc. 69 Profit Growth Debt Cash Flow Return 7/9 Safe 80

BLFS BioLife Solutions, Inc… Emerging Unit Sold 69 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 81

ANIP ANI Pharmaceuticals, I… 69 Profit Growth Debt Cash Flow Return 7/9 Grey 82

ABT Abbott Laboratories 69 Profit Growth Debt Cash Flow Return 5/9 Safe 83

VRCA Verrica Pharmaceutical… Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 84

VEEV Veeva Systems Inc. 68 Profit Growth Debt Cash Flow Return 6/9 Safe 85

SNWV SANUWAVE Health, Inc. Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 86

RGEN Repligen Corporation 68 Profit Growth Debt Cash Flow Return 7/9 Safe 87

IVVD Invivyd, Inc. Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 2/9 Distress 88

IONS Ionis Pharmaceuticals,… Emerging 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 89

HQY HealthEquity, Inc. 68 Profit Growth Debt Cash Flow Return 9/9 Safe 90

HOLX Hologic, Inc. 68 Profit Growth Debt Cash Flow Return 6/9 Safe 91

ADUS Addus HomeCare Corpora… 68 Profit Growth Debt Cash Flow Return 7/9 Safe 92

ACAD ACADIA Pharmaceuticals… Check Earnings 68 Profit Growth Debt Cash Flow Return 5/9 Safe 93

XOMAO XOMA Royalty Corporati… Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 6/9 - 94

XOMA XOMA Royalty Corp Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 95

VRDN Viridian Therapeutics,… Emerging Check Earnings Data Issue 67 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 96

SYK Stryker Corporation 67 Profit Growth Debt Cash Flow Return 4/9 Safe 97

STE STERIS plc 67 Profit Growth Debt Cash Flow Return 9/9 Safe 98

QTTB Q32 Bio Inc. Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 99

NHC National HealthCare Co… 67 Profit Growth Debt Cash Flow Return 7/9 Safe 100

NAMS NewAmsterdam Pharma Co… Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 2/9 Safe

How the Financial Health Score is calculated

Each company receives a composite score from 0 to 100 built from six dimensions derived from SEC filings. The dimensions are family-specific: a company is scored on the metrics that matter for its business type, then ranked against direct peers rather than across every industry. A score is a company's standing within its peer group, not an absolute cross-industry rating; a 70 for a bank and a 70 for a software company both mean "top of its family," not "equally strong businesses."

Each of the six dimensions is scored as a percentile within the family (how the company ranks against its peers on that dimension). The overall score is the rounded average of the six, with any dimension we can't compute counted as zero out of a fixed denominator of six, so incomplete data can't inflate a ranking.

Operating companies, energy and utilities are scored on Profitability, Growth, Leverage, Liquidity, Cash Flow, and Returns.
Banks are scored on Earnings, Growth, Capital, Efficiency, Credit Quality, and Stability.
Insurers are scored on Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, and Stability.
REITs are scored on FFO Margin, FFO Growth, Leverage, Interest Coverage, AFFO Margin, and Dividend Coverage.
Emerging (pre-profit) companies are scored on Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, and Balance Sheet.
Warrants, preferred shares and duplicate listings that share a parent company's financials are automatically filtered from the ranking.

The Piotroski F-Score (0 to 9) measures fundamental strength using nine binary accounting tests; the Altman Z-Score estimates bankruptcy risk, classifying companies into Safe, Grey, or Distress zones. These two signals are shown alongside the composite score for additional perspective.